- Beat earnings estimates in all of the last 4 quarters
- Excellent financial health (Piotroski 7/9)
- High gross margin of 73.3%
GlaxoSmithKline plc stock price ended at $24.95 on Friday, after losing 0.280%
(Updated on Jul 31, 2026)
The GlaxoSmithKline plc stock price fell by -0.280% on the last day (Friday, 31st Jul 2026) from $25.02 to $24.95. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 0.727% from a day low at $24.77 to a day high of $24.95. The price has fallen in 4 of the last 10 days and is down by -3.14% for this period. Volume has increased on the last day by 1 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 1 thousand shares were bought and sold for approximately $32.21 thousand.
The stock lies in the middle of a wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 2.13% during the next 3 months and, with a 90% probability hold a price between $24.42 and $27.75 at the end of this 3-month period.
GLAXF Signals & Forecast
There are few to no technical positive signals at the moment. The GlaxoSmithKline plc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $25.68 and $25.88. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -7.59%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). GlaxoSmithKline plc gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for GlaxoSmithKline plc stock
GlaxoSmithKline plc finds support from accumulated volume at $24.66 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0.180 between high and low, or 0.727%. For the last week the stock has had daily average volatility of 2.54%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (GLAXF) For The Upcoming Trading Day Of Monday 3rd
For the upcoming trading day on Monday, 3rd we expect GlaxoSmithKline plc to open at $24.89, and during the day (based on 14 day Average True Range), to move between $24.70 and $25.20, which gives a possible trading interval of +/-$0.508 (+/-2.06%) up or down from last closing price. If GlaxoSmithKline plc takes out the full calculated possible swing range there will be an estimated 2.06% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $25.01 (0.24%) than the support at $24.66 (1.15%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Dividend Warning For GLAXF
Dividend coming up for GLAXF: Ex-dividend date (Thursday 13th August, 2026) is 10 days away. The dividend is $0.230.Is GlaxoSmithKline plc stock A Buy?
The GlaxoSmithKline plc stock holds several negative signals and despite the positive trend, we believe GlaxoSmithKline plc will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
Current score:
-2.884
Sell Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 3, 2026 - $24.89 ( 0.240%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
GLAXF Performance
Trading levels for GLAXF
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 25.07 | 0.481% |
| R2 | 25.00 | 0.205% |
| R1 | 24.96 | 0.0351% |
| Price | 24.95 | |
| S1 | 24.82 | -0.516% |
| S2 | 24.78 | -0.686% |
| S3 | 24.71 | -0.96% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 25.33 | 1.53% |
| R2 | 25.12 | 0.671% |
| R1 | 25.01 | 0.240% |
| Price | 24.95 | |
| S1 | 24.66 | -1.15% |
| S2 | 24.58 | -1.50% |
| S3 | 24.25 | -2.79% |
GLAXF Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Aug 13, 2026 | Aug 13, 2026 | Oct 08, 2026 | $0.226 | 0.87% |
| 2 | Nov 10, 2025 | May 15, 2026 | Jul 09, 2026 | $0.227 | 0.88% |
| 3 | May 14, 2026 | May 14, 2026 | Jul 09, 2026 | $0.229 | 0.88% |
| 4 | Nov 11, 2024 | Feb 20, 2026 | Apr 09, 2026 | $0.246 | 0.81% |
| 5 | Feb 19, 2026 | Feb 19, 2026 | Apr 09, 2026 | $0.246 | 0.84% |
FAQ
Click here for our free guide on how to buy GlaxoSmithKline plc Stock.
Buy GLAXF